Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol

Molecular Pharmacology

Volumn 50, Issue 6, 1996, Pages 1541-1550

  Ilyin, V I ^a,b   Whittemore, E R ^a   Guastella, J ^a   Weber, E ^a   Woodward, R M ^a,c  

^a Department of Pharmacokinetics and Drug Metabolism   (United States)

^b INSTITUTE OF CELL BIOPHYSICS   (Russian Federation)

^c Acea Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLUTAMIC ACID; GLYCINE; HALOPERIDOL; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PHENCYCLIDINE; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT;

ANIMAL CELL; ARTICLE; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; DRUG SELECTIVITY; MICROINJECTION; MOLECULAR CLONING; NERVE CELL CULTURE; NONHUMAN; OOCYTE; PATCH CLAMP; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; XENOPUS LAEVIS;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; CLONING, MOLECULAR; HALOPERIDOL; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; XENOPUS LAEVIS;

EID: 0030474725     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hollmann, M., and S. Heinemann. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:31-108 (1994).
2. Moriyoshi, K., M. Masu, T. Ishii, R. Shigemoto, N. Mizuno, and S. Nakanishi. Molecular cloning and characterization of the rat NMDA receptor. Nature (Lond.) 354:31-37 (1991).
3. Monyer, H., R. Sprengel, R. Schoepfer, A. Herb, M. Higuchi, H. Lomeli, N. Burnashev, B. Sakmann, and P. H. Seeburg. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science (Washington D. C.) 256:1217-1221 (1992).
4. Kutsuwada, T., N. Kashiwabuchi, H. Mori, K. Sakimua, E. Kushiya, K. Araki, H. Meguro, H. Masaki, T. Kumanihsi, M. Arakawa, and M. Mishina. Molecular diversity of the NMDA receptor channel. Nature (Lond.) 358:36-41 (1992).
5. Sheng, M., J. Cummings, L. A. Roldan, Y. N. Jan, and L. Y. Jan. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature (Lond.) 368:144-147 (1994).
6. Monyer, H., N. Burnashev, D. J. Laurie, B. Sakmann, and P. H. Seeburg. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529-540 (1994).
7. Zukin, R. S., and M. V. L. Bennett. Alternatively spliced isoforms of the NMDAR1 receptor subunit. Trends Neurosci. 18:306-313 (1995).
8. Priestly, T., P. Laughton, J. Myers, B. Le Bourdelles, J. Kirby, and P. J. Whiting. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Mol. Pharmacol. 48:841-848 (1995).
9. Williams, K. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44:851-859 (1993).
10. Woodward, R. M., J. E. Huettner, J. Guastella, J. F. W. Keana, and E. Weber. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol. Pharmacol. 47:568-581 (1995).
11. Ben-Ari, Y., E. Cherubini, and K. Krnjevic. Changes in voltage-dependence of NMDA currents during development. Neurosci. Lett. 94:88-92 (1988).
12. Vicini, S., J. F. Wang, J. S. Poling, and D. R. Grayson. Functional and pharmacological differences between recombinant and native NMDA receptors. Soc. Neurosci. Abstr. 21:86 (1995).
13. Williams, K., S. L. Russell, Y. M. Shen, and P. B. Molinoff. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron 10:267-278 (1993).
14. Choi, D. W., and S. M. Rothman. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:171-182 (1990).
15. Muir, K. W., and K. R. Lees. Clinical experience with excitatory amino acid antagonist drugs. Stroke 26:503-513 (1995).
16. Peroutka, S. J., and S. H. Snyder. Relationship of neuroleptic drug effects at brain dopamine, serotonin, α-adrenergic, and histamine receptors to clinical potency. Am. J. Psychiatry 137:1518-1522 (1980).
17. Itzhak, Y., and I. Stein. Sigma binding sites in the brain: an emerging concept for multiple sites and their relevance to psychiatric disorders. Life Sd. 47:1073-1081 (1990).
18. MacDonald, J. W., and M. V. Johnston. Pharmacology of NMDA-induced brain injury in an in vivo perinatal rat model. Synapse 6:179-188 (1990).
19. Fletcher, E. J., and J. F. MacDonald. Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones. Eu. J. Pharmacol. 235:291-295 (1993).
20. Leeson, P. D. Glycine-site N-methyl-D-aspartate receptor antagoniste, in Drug Design for Neuroscience (A. P. Kozikowski, ed.). Raven Press, New York, 339-381 (1993).
21. Sugihara, H., K. Moriyoshi, T. Ishii, M. Masu, and S. Nakanishi. Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem. Biophys. Res. Commun. 185:826-832 (1992).
22. Ilyin, V. I., J. Guastella, S. X. Cai, E. Weber, and R. M. Woodward. Subunit-specific inhibition of cloned NMDA receptors by haloperidol. Soc. Neurosci. Abstr. 20:1143 (1994).
23. Whittemore, E. R., D. T. Loo, J. A. Watt, and C. W. Cotman. A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture. Neuroscience 67:921-932 (1995).
24. Hamill, O. P., Marty A., Neher E., Sakmann B., and F. J. Sigworth. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflueg. Arch. Eur. J. Physiol. 391:85-100 (1981).
25. Colquhoun, D., and F. J. Sigworth. Fitting and statistical analysis of single-channel records, in Single-Channel Recording (B. Sakmann and E. Neher, eds.). Plenum Press, New York/London, 483-587 (1995).
26. Fenwick, E. M., Marty, A., and E. Neher. Sodium and calcium channels in bovine chromaffin cells. J. Physiol. (Lond.) 331:599-635 (1982).
27. MacDonald, J. F., M. C. Bartlett, I. Mody, P. Paphapill, J. N. Reynolds, M. W. Slater, J. H. Schneiderman, and P. S. Pennefather. Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J. Physiol. (Lond.) 432:483-508 (1991).
28. Arellano, R. O., R. M. Woodward, and R. Miledi. A monovalent cationic conductance that is blocked by extracellular divalent cations in Xenopus oocytes. J. Physiol. (Lond.) 484:3:593-604 (1995).
29. Ascher, P., P. Bregestovski, and L. Nowak. N-Methyl-D-aspartate-activated channels of mouse central neurones in magnesium-free solutions. J. Physiol. (Lond.) 399:207-226 (1988).
30. Jahr, C. E., and C. F. Stevens. Glutamate activates multiple single channel conductances in hippocampal neurons. Nature (Lond.) 325:522-525 (1987).
31. Huettner, J. E., and B. P. Bean. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc. Natl. Acad. Sci. USA 85:1307-1311 (1988).
32. Benveniste, M., and M. L. Mayer. Multiple effects of spermine on N-methyl-D-aspartate receptor responses of rat cultured hippocampal neurons. J. Physiol. (Lond.) 464:131-163 (1993)
33. Williams, K. Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-D-aspartate receptors. Mol. Pharmacol. 46:161-168 (1994).
34. Zhong, J., S. L. Russel, D. B. Prichett, P. B. Molinoff, and K. Williams. Expression of messenger RNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol. Pharmacol. 45:846-853 (1994).
35. Legendre, P., and G. L. Westbrook. Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism. Mol. Pharmacol. 40:289-298 (1991).
36. Yamamoto, H., Y. Yamamoto, N. Sagi, V. Klenerova, K. Goji, N. Kawai, A. Baba, E. Takamori, and T. Moroji. Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via σ1 site. J. Neurosci. 15:731-736 (1995).
37. Stern, P., P. Behe, R. Schoepfer, and D. Colquhoun. Single-channel conductances of NMDA receptors expressed from cloned cDNAs: comparison with native receptors. Proc. R. Soc. Lond. B Biol. Sci. 250:271-277 (1992).
38. Chenard, B. L., J. Bordner, T. W. Butler, L. K. Chambers, M. A. Collins, D. L. De Costa, M. F. Ducat, M. L. Dumont, C. B. Fox, E. E. Mena, F. S. Meniti, J. Nielsen, M. J. Pagnozzi, K. E. G. Richter, R. T. Ronau, I A. Shalaby, J. Z. Stemple, and W. F. White. (1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses. J. Med. Chem. 38:3138-3145 (1995).
39. Banerjee, S. P., L. G. Zuck, E. Yablonsky-Alter, and T. I. Lidsky. Glutamate agonist activity: implications for antipsychotic drug actions and schizophrenia. Neuroreport 6:2500-2504 (1995).